Actuality of the use of acetazolamide as a diuretic: usefulness in refractory edema and in aldosteroneantagonist- related hyperkalemia
Vigencia de la acetazolamida en la terapéutica diurética actual: aplicaciones en el edema refractario y la hiperpotasemia relacionada al bloqueo aldosterónico
Read
15139
Timeswas read the article
3297
Total PDF
11842
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 54 | 10 | 64 |
| 2025 5 | 227 | 65 | 292 |
| 2025 4 | 132 | 39 | 171 |
| 2025 3 | 196 | 70 | 266 |
| 2025 2 | 150 | 53 | 203 |
| 2025 1 | 147 | 41 | 188 |
| 2024 12 | 134 | 38 | 172 |
| 2024 11 | 115 | 67 | 182 |
| 2024 10 | 97 | 80 | 177 |
| 2024 9 | 94 | 52 | 146 |
| 2024 8 | 108 | 100 | 208 |
| 2024 7 | 111 | 98 | 209 |
| 2024 6 | 116 | 56 | 172 |
| 2024 5 | 116 | 58 | 174 |
| 2024 4 | 100 | 67 | 167 |
| 2024 3 | 84 | 35 | 119 |
| 2024 2 | 66 | 39 | 105 |
| 2024 1 | 87 | 38 | 125 |
| 2023 12 | 73 | 28 | 101 |
| 2023 11 | 81 | 33 | 114 |
| 2023 10 | 127 | 50 | 177 |
| 2023 9 | 133 | 34 | 167 |
| 2023 8 | 114 | 20 | 134 |
| 2023 7 | 114 | 37 | 151 |
| 2023 6 | 109 | 36 | 145 |
| 2023 5 | 118 | 44 | 162 |
| 2023 4 | 111 | 24 | 135 |
| 2023 3 | 116 | 42 | 158 |
| 2023 2 | 87 | 29 | 116 |
| 2023 1 | 137 | 37 | 174 |
| 2022 12 | 103 | 46 | 149 |
| 2022 11 | 122 | 53 | 175 |
| 2022 10 | 104 | 81 | 185 |
| 2022 9 | 147 | 43 | 190 |
| 2022 8 | 114 | 68 | 182 |
| 2022 7 | 112 | 53 | 165 |
| 2022 6 | 80 | 45 | 125 |
| 2022 5 | 102 | 80 | 182 |
| 2022 4 | 103 | 57 | 160 |
| 2022 3 | 99 | 44 | 143 |
| 2022 2 | 118 | 44 | 162 |
| 2022 1 | 127 | 19 | 146 |
| 2021 12 | 98 | 40 | 138 |
| 2021 11 | 95 | 43 | 138 |
| 2021 10 | 97 | 40 | 137 |
| 2021 9 | 92 | 49 | 141 |
| 2021 8 | 149 | 42 | 191 |
| 2021 7 | 114 | 42 | 156 |
| 2021 6 | 120 | 30 | 150 |
| 2021 5 | 106 | 27 | 133 |
| 2021 4 | 229 | 48 | 277 |
| 2021 3 | 158 | 30 | 188 |
| 2021 2 | 152 | 13 | 165 |
| 2021 1 | 93 | 19 | 112 |
| 2020 12 | 105 | 19 | 124 |
| 2020 11 | 96 | 17 | 113 |
| 2020 10 | 87 | 17 | 104 |
| 2020 9 | 110 | 17 | 127 |
| 2020 8 | 77 | 14 | 91 |
| 2020 7 | 122 | 6 | 128 |
| 2020 6 | 104 | 19 | 123 |
| 2020 5 | 138 | 7 | 145 |
| 2020 4 | 160 | 20 | 180 |
| 2020 3 | 106 | 11 | 117 |
| 2020 2 | 106 | 19 | 125 |
| 2020 1 | 126 | 32 | 158 |
| 2019 12 | 143 | 21 | 164 |
| 2019 11 | 115 | 32 | 147 |
| 2019 10 | 105 | 24 | 129 |
| 2019 9 | 129 | 26 | 155 |
| 2019 8 | 102 | 16 | 118 |
| 2019 7 | 92 | 27 | 119 |
| 2019 6 | 93 | 19 | 112 |
| 2019 5 | 109 | 26 | 135 |
| 2019 4 | 135 | 34 | 169 |
| 2019 3 | 72 | 15 | 87 |
| 2019 2 | 52 | 25 | 77 |
| 2019 1 | 54 | 24 | 78 |
| 2018 12 | 86 | 32 | 118 |
| 2018 11 | 150 | 25 | 175 |
| 2018 10 | 116 | 15 | 131 |
| 2018 9 | 65 | 19 | 84 |
| 2018 8 | 68 | 7 | 75 |
| 2018 7 | 56 | 23 | 79 |
| 2018 6 | 67 | 10 | 77 |
| 2018 5 | 76 | 10 | 86 |
| 2018 4 | 76 | 10 | 86 |
| 2018 3 | 89 | 14 | 103 |
| 2018 2 | 58 | 2 | 60 |
| 2018 1 | 95 | 13 | 108 |
| 2017 12 | 101 | 6 | 107 |
| 2017 11 | 61 | 8 | 69 |
| 2017 10 | 52 | 8 | 60 |
| 2017 9 | 50 | 13 | 63 |
| 2017 8 | 30 | 12 | 42 |
| 2017 7 | 29 | 12 | 41 |
| 2017 6 | 39 | 18 | 57 |
| 2017 5 | 51 | 25 | 76 |
| 2017 4 | 35 | 5 | 40 |
| 2017 3 | 18 | 3 | 21 |
| 2017 2 | 16 | 7 | 23 |
| 2017 1 | 16 | 9 | 25 |
| 2016 12 | 65 | 4 | 69 |
| 2016 11 | 43 | 8 | 51 |
| 2016 10 | 63 | 5 | 68 |
| 2016 9 | 104 | 3 | 107 |
| 2016 8 | 144 | 1 | 145 |
| 2016 7 | 118 | 7 | 125 |
| 2016 6 | 86 | 0 | 86 |
| 2016 5 | 129 | 0 | 129 |
| 2016 4 | 72 | 0 | 72 |
| 2016 3 | 60 | 0 | 60 |
| 2016 2 | 79 | 0 | 79 |
| 2016 1 | 91 | 0 | 91 |
| 2015 12 | 74 | 0 | 74 |
| 2015 11 | 76 | 0 | 76 |
| 2015 10 | 62 | 0 | 62 |
| 2015 9 | 49 | 0 | 49 |
| 2015 8 | 73 | 0 | 73 |
| 2015 7 | 48 | 0 | 48 |
| 2015 6 | 33 | 0 | 33 |
| 2015 5 | 42 | 0 | 42 |
| 2015 4 | 5 | 0 | 5 |
Show all
